Contact Us
 • 
Home
Search 

Clinical Trials > DAHANCA-21  

  • Information
  • Sites - Open
  • Sites - Interested
DAHANCA-21   

Title

Hyperbaric oxygen treatment of mandibular osteoradionecrosis.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
III CTIMP Open 18 and over Dr Lone Forner (Cheif Investigator and Sponsor). Prof Shaw is the lead investigator in the UK. Eudract No:
Isrctn No: NCT00760682
0

Purpose

The objective of the study is to evaluate the effect of HBO on mandibular ORN as an adjunctive to surgical treatment in patients previously irradiated for head and neck cancer.


Trial Lead Organisations

Copenhagen University, LCTU, University of Liverpool


Trial Start Date

12/05/2014


Trial Coordinator

Binyam Tesfaye


Trial Coordinator Email Address

btesfaye@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 5479



UK: ENGLAND

  • Bradford, Bradford Royal Infirmary (Michael Ho)
  • Chichester, Hyperbaric Medicine Unit (Chichester) (Mark Glover)
  • Chichester, St. Richard's Hospital (Chichester) (Peyman Alam)
  • Harrow, Northwick Park Hospital (Harrow) (Jim McCaul)
  • Harrow, Northwick Park Hospital (Harrow) (Abdul Ahmed)
  • Kingston Upon Hull, North of England Hyperbaric Service (Kingston Upon Hull) (Gerard Purdy)
  • Leeds, Leeds General Infirmary (Anastasios Kanatas)
  • Liverpool, University Hospital Aintree (Richard Shaw)
  • Wirral, North West Emergency Recompression Unit, Murrayfield Hospital (Wirral) (Tristan Cope)

UK

  • Rugby,, Hospital of St Cross (Rugby) (Michael Gonevski)

UK: ENGLAND

  • Birmingham, Queen Elizabeth Hospital (Birmingham) (Prav Praveen)
  • Plymouth, The Hyperbaric Medical Centre (Plymouth) (Christine Penny)
  • Portsmouth, Queen Alexandra Hospital (Portsmouth) (Tim Mellor)
  • Worthing, Worthing Hospital (Madan Ethunandan)